On June 25, 2020, EastWest Bioscience Inc. (TSXV:EAST) closed the transaction. The company has issued 1,992,727 common shares at a price of CAD 0.05 per share for the gross proceeds of CAD 99,636.35. TSX Venture Exchange approved the deal. The round included participation from Summit Bancorp.